198 related articles for article (PubMed ID: 35204461)
41. Clinical significance of ephrin (eph)-A1, -A2, -a4, -a5 and -a7 receptors in pancreatic ductal adenocarcinoma.
Giaginis C; Tsourouflis G; Zizi-Serbetzoglou A; Kouraklis G; Chatzopoulou E; Dimakopoulou K; Theocharis SE
Pathol Oncol Res; 2010 Jun; 16(2):267-76. PubMed ID: 19949912
[TBL] [Abstract][Full Text] [Related]
42. Small breast epithelial mucin tumor tissue expression is associated with increased risk of recurrence and death in triple-negative breast cancer patients.
Liu L; Liu Z; Qu S; Zheng Z; Liu Y; Xie X; Song F
Diagn Pathol; 2013 May; 8():71. PubMed ID: 23635316
[TBL] [Abstract][Full Text] [Related]
43. ProNGF promotes brain metastasis through TrkA/EphA2 induced Src activation in triple negative breast cancer cells.
Cicero J; Trouvilliez S; Palma M; Ternier G; Decoster L; Happernegg E; Barois N; Van Outryve A; Dehouck L; Bourette RP; Adriaenssens E; Lagadec C; Tarhan CM; Collard D; Souguir Z; Vandenhaute E; Maubon G; Sipieter F; Borghi N; Shimizu F; Kanda T; Giacobini P; Gosselet F; Maubon N; Le Bourhis X; Van Seuningen I; Mysiorek C; Toillon RA
Exp Hematol Oncol; 2023 Dec; 12(1):104. PubMed ID: 38072918
[TBL] [Abstract][Full Text] [Related]
44. Comparative integromics on Eph family.
Katoh M; Katoh M
Int J Oncol; 2006 May; 28(5):1243-7. PubMed ID: 16596241
[TBL] [Abstract][Full Text] [Related]
45. Radiation prevents tumor progression by inhibiting the miR‑93‑5p/EphA4/NF‑κB pathway in triple‑negative breast cancer.
Pan C; Shao S; Gu Y; Ni Q
Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36866759
[TBL] [Abstract][Full Text] [Related]
46. Expression and tyrosine phosphorylation of Eph receptors suggest multiple mechanisms in patterning of the visual system.
Connor RJ; Menzel P; Pasquale EB
Dev Biol; 1998 Jan; 193(1):21-35. PubMed ID: 9466885
[TBL] [Abstract][Full Text] [Related]
47. Ephrin/ephrin receptor expression during early stages of mouse inner ear development.
Saeger BM; Suhm M; Neubüser A
Dev Dyn; 2011 Jun; 240(6):1578-85. PubMed ID: 21465626
[TBL] [Abstract][Full Text] [Related]
48. Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival.
Tozbikian G; Brogi E; Kadota K; Catalano J; Akram M; Patil S; Ho AY; Reis-Filho JS; Weigelt B; Norton L; Adusumilli PS; Wen HY
PLoS One; 2014; 9(12):e114900. PubMed ID: 25506917
[TBL] [Abstract][Full Text] [Related]
49. Sizes of interface residues account for cross-class binding affinity patterns in Eph receptor-ephrin families.
Guo FY; Lesk AM
Proteins; 2014 Mar; 82(3):349-53. PubMed ID: 24105818
[TBL] [Abstract][Full Text] [Related]
50. TTK is a favorable prognostic biomarker for triple-negative breast cancer survival.
Xu Q; Xu Y; Pan B; Wu L; Ren X; Zhou Y; Mao F; Lin Y; Guan J; Shen S; Zhang X; Wang C; Zhong Y; Zhou L; Liang Z; Zhao H; Sun Q
Oncotarget; 2016 Dec; 7(49):81815-81829. PubMed ID: 27833085
[TBL] [Abstract][Full Text] [Related]
51. The prognostic significance of cyclin D1 expression in patients with triple-negative breast cancer.
Bolat Kucukzeybek B; Vedat Bayoglu I; Kucukzeybek Y; Alacacioglu A; Yigit S; Akder Sari A; Akyol M; Oktay Tarhan M
J BUON; 2017; 22(4):947-952. PubMed ID: 28952212
[TBL] [Abstract][Full Text] [Related]
52. EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Fukuchi M; Nakajima M; Kuwano H
Int J Cancer; 2003 Feb; 103(5):657-63. PubMed ID: 12494475
[TBL] [Abstract][Full Text] [Related]
53. Nephric duct insertion requires EphA4/EphA7 signaling from the pericloacal mesenchyme.
Weiss AC; Airik R; Bohnenpoll T; Greulich F; Foik A; Trowe MO; Rudat C; Costantini F; Adams RH; Kispert A
Development; 2014 Sep; 141(17):3420-30. PubMed ID: 25139858
[TBL] [Abstract][Full Text] [Related]
54. Clinical characteristics and prognostic analysis of triple-negative breast cancer patients.
Yuan N; Meng M; Liu C; Feng L; Hou L; Ning Q; Xin G; Pei L; Gu S; Li X; Zhao X
Mol Clin Oncol; 2014 Mar; 2(2):245-251. PubMed ID: 24649341
[TBL] [Abstract][Full Text] [Related]
55. Expression of ROR1 has prognostic significance in triple negative breast cancer.
Chien HP; Ueng SH; Chen SC; Chang YS; Lin YC; Lo YF; Chang HK; Chuang WY; Huang YT; Cheung YC; Shen SC; Hsueh C
Virchows Arch; 2016 May; 468(5):589-95. PubMed ID: 26874851
[TBL] [Abstract][Full Text] [Related]
56. The Expression Profile and Prognostic Values of EPHA Family Members in Breast Cancer.
Zhang X
Front Oncol; 2021; 11():619949. PubMed ID: 34221956
[TBL] [Abstract][Full Text] [Related]
57. Clinical implication of leucine zipper/EF hand-containing transmembrane-1 overexpression in the prognosis of triple-negative breast cancer.
Wang CA; Liu Q; Chen Y; Liu S; Xu J; Cui X; Zhang Y; Piao L
Exp Mol Pathol; 2015 Apr; 98(2):254-9. PubMed ID: 25617527
[TBL] [Abstract][Full Text] [Related]
58. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
[TBL] [Abstract][Full Text] [Related]
59. Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel.
Fountzilas G; Dafni U; Bobos M; Batistatou A; Kotoula V; Trihia H; Malamou-Mitsi V; Miliaras S; Chrisafi S; Papadopoulos S; Sotiropoulou M; Filippidis T; Gogas H; Koletsa T; Bafaloukos D; Televantou D; Kalogeras KT; Pectasides D; Skarlos DV; Koutras A; Dimopoulos MA
PLoS One; 2012; 7(6):e37946. PubMed ID: 22679488
[TBL] [Abstract][Full Text] [Related]
60. Epithelial cell adhesion molecule and epithelial-mesenchymal transition are associated with vasculogenic mimicry, poor prognosis, and metastasis of triple negative breast cancer.
Wu Q; Wang J; Liu Y; Gong X
Int J Clin Exp Pathol; 2019; 12(5):1678-1689. PubMed ID: 31933986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
